Hepatitis B: Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus. It is a major global health problem. It can cause chronic infection and puts people at high risk of death from cirrhosis and liver cancer.Symptoms: Most people do not experience any symptoms during the acute infection phase. However, some people have acute illness with symptoms that last several weeks, including yellowing of the skin and eyes (jaundice), dark urine, extreme fatigue, nausea, vomiting and abdominal pain.
Causes: Hepatitis B spreads in several ways. You can get it from sex with someone who's sick or by sharing a needle when using street drugs. The virus also can pass from a mother to her newborn child at birth or soon afterward. Diagnosis:Laboratory diagnosis of hepatitis B infection focuses on the detection of the hepatitis B surface antigen HBsAg. Acute HBV infection is characterized by the presence of HBsAg and immunoglobulin M (IgM) antibody to the core antigen, HBcAg. The presence of HBeAg indicates that the blood and body fluids of the infected individual are highly contagious.
Treatment There is no specific treatment for acute hepatitis B. Therefore, care is aimed at maintaining comfort and adequate nutritional balance, including replacement of fluids lost from vomiting and diarrhoea. statistics: Of 267 cases enrolled in the study, 143 were children and 124 were adults. Males (62.54%) outnumbered females (37.45%). Total 23.22% (62/267) cases developed encephalopathy during their illness and were therefore labelled as acute hepatic failure. The viral aetiology was confirmed in 161 (60.29%) cases while in 106 (39.70%) cases no hepatitis virus could be detected.